SIM1 and obesity due to melanocortin 4 receptor deficiency: Application of a similar synthetic transcriptional activation therapeutic strategy has shown exciting promise in vivo in mice, where a dCas9-based activator combined with locus-specific guide RNA delivered to hypothalamus was capable of rescuing obesity phenotypes in Sim1 and Mc4r heterozygous mutant mice [95].